Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Put/Call Ratio
Increase
Decrease
Funds Holding
3,031
Funds Holding Change
+26
Funds Holding Growth
+0.9%
Value
$949B
Holding in Top 10
1,225
Top 10 Change
+46
Top 10 Growth
+4%
Value Growth
+7%
New
124
Increased
1,385
Reduced
1,367
Closed
60
Capital Inflow
$115B
Capital Outflow
$29B
Net Capital Flow
+$86B
Capital Flow Change
+$85.9B
Calls
$13.3B
Puts
$14B
Net Calls
-$694M
Put/Call Ratio
1.05